Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Option Care Health (OPCH) Shares Outstanding (Diluted Average) (2018 - 2025)

Option Care Health (OPCH) has disclosed Shares Outstanding (Diluted Average) for 13 consecutive years, with $163.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 5.48% year-over-year to $163.4 million, compared with a TTM value of $163.4 million through Dec 2025, down 5.48%, and an annual FY2025 reading of $163.4 million, down 5.48% over the prior year.
  • Shares Outstanding (Diluted Average) was $163.4 million for Q4 2025 at Option Care Health, down from $164.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $183.0 million in Q3 2022 and bottomed at $163.4 million in Q4 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $176.7 million, with a median of $180.7 million recorded in 2021.
  • The sharpest move saw Shares Outstanding (Diluted Average) rose 2.43% in 2021, then decreased 5.48% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $181.2 million in 2021, then grew by 0.48% to $182.1 million in 2022, then fell by 0.93% to $180.4 million in 2023, then dropped by 4.17% to $172.8 million in 2024, then fell by 5.48% to $163.4 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for OPCH at $163.4 million in Q4 2025, $164.6 million in Q3 2025, and $165.4 million in Q2 2025.